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Abstract
Adhesion to host cells is an initial and important step in Acinetobacter baumannii pathogenesis. However, there is relatively
little information on the mechanisms by which A. baumannii binds to and interacts with host cells. Adherence to
extracellular matrix proteins, such as fibronectin, affords pathogens with a mechanism to invade epithelial cells. Here, we
found that A. baumannii adheres more avidly to immobilized fibronectin than to control protein. Free fibronectin used as a
competitor resulted in dose-dependent decreased binding of A. baumannii to fibronectin. Three outer membrane
preparations (OMPs) were identified as fibronectin binding proteins (FBPs): OMPA, TonB-dependent copper receptor, and
34 kDa OMP. Moreover, we demonstrated that fibronectin inhibition and neutralization by specific antibody prevented
significantly the adhesion of A. baumannii to human lung epithelial cells (A549 cells). Similarly, A. baumannii OMPA
neutralization by specific antibody decreased significantly the adhesion of A. baumannii to A549 cells. These data indicate
that FBPs are key adhesins that mediate binding of A. baumannii to human lung epithelial cells through interaction with
fibronectin on the surface of these host cells.
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Introduction
The ability of bacteria to interact with eukaryotic cells, leading
to their own internalization, seems to be a critical event in the
pathogenesis process of several microorganisms [1]. Invasive
bacteria reach a compartment in which they are protected against
host clearance mechanisms, can replicate and prepare themselves
to gain access to tissues and circulatory system.
Acinetobacter baumannii have long been considered as nosocomial
pathogen with low virulence. However, several recent studies have
shown that this microorganism is more virulent than expected [2].
Interaction between A. baumannii and the host epithelial cells is
important in determining the outcome of infections. Various
studies have shown that A. baumannii are able to adhere to and
invade human epithelial cells; and induce epithelial cells death [3–
6]. However, there is relatively little information on the
mechanisms by which A. baumannii bind to and interact with host
cells.
Since the initial reports on A. baumannii adherence and invasion,
attempts have been made to elucidate the mechanisms by which A.
baumannii promote adherence and invasion in host cells. Acineto-
bacter sp and A. baumannii used pili, fimbrial-like structures and
outer membrane protein A (OmpA) to facilitate its adhesion and
invasion in host cells [3,5,7]. However, the host cells surface
factors that mediate adherence of A. baumannii are largely
uncharacterized. Potential host cell receptors for A. baumannii
adhesion can include extracellular matrix (ECM) proteins, such as
integrin and fibronectin; which have been used as bridging
molecules to achieve the attachment and the invasion of host cells
by pathogens like Pseudomonas aeruginosa, Escherichia coli, Streptoccocus
pyogenes and Staphylococcus aureus [8–11].
In support of this, bacterial fibronectin-binding proteins (FBPs)
were consistently identified as key players in the process of host
cells adhesion to and internalization of different pathogens [12].
FBPs also mediate the attachment of bacteria to implanted
material, which becomes coated with host proteins [13], indicating
a possible role in infections associated with catheters and
prosthetic devices. Most of them are members of large gram
negative bacteria, and more thoroughly described in E. coli with
most extensive attention [12]. At least 10 different proteins from E.
coli bind to fibronectin leading to internalization of E. coli by
human host cells including epithelial cells [12].
In the case of A. baumannii, only one study has reported in vitro
that A. baumannii adhesive property involves fibronectin [14].
However, the characterization of the role played by this protein is
still limited and the FBPs mediating the binding between
fibronectin and A. baumannii need to be determined. The present
study, therefore, aimed to examinate the binding of fibronectin to
A. baumannii and the identification of the FBPs involved in this
process.
Results
Interaction of A. baumannii with immobilized fibronectin
We showed that all A. baumannii strains studied here adhered
more to fibronectin pre-coated wells than to BSA precoated wells.
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The adhesion of A. baumannii to immobilized fibronectin was
significantly greater for 77 and ATCC 19606 strains than for 113-
16 strain (Fig. 1A). Moreover, soluble fibronectin (from 10 to
1,000 mg/mL) used as a competitor was able to almost completely
inhibit all three A. baumannii strains binding with an elective
plasmatic fibronectin concentration inhibiting bacterial adherence
at 50% (IC50) of <200, 500 and 10 mg/mL, respectively (Fig. 1B).
In contrast, incubation of all three A. baumannii strains with BSA
(1,000 mg/mL) did not inhibit significantly the binding of A.
baumannii ATCC 19606, 77 and 113-16 strains to immobilized
fibronectin. From these data, we suggest that A. baumannii has
specific ligands for fibronectin.
Identification of A. baumannii FBPs
After growing the 3 strains of A. baumannii for 4 h at 37uC, the
enriched OMPs electrophoretic profiles were compared. We
observed a significant loss of a 29 kDa OMP in the 113-16 strain
when compared with the ATCC 19606 and 77 strains. Western
blotting analysis performed following 10% SDS-PAGE of OMPs
of each A. baumannii strain (ATCC 19606, 77 and 113-16) and their
transfer to nitrocellulose membranes revealed that incubation of
this nitrocellulose membrane with fibronectin (10 mg/mL, 1 h)
formed three stables complexes with fibronectin for each strain
(Fig. 2A). The three bands have apparent molecular masses of 80,
36 and 32 kDa (Fig. 2A). To identify these proteins which bind the
fibronectin, we excised from SDS-PAGE gel the bands represent-
ing fibronectin-binding proteins (FBPs) and subjected them to MS-
MS/MS analysis. Data obtained from peptide mass fingerprinting
were matched against the NCBI database (http://www.ncbi.nlm.
nih.gov). The amino acid sequences identification revealed amino
acid identity of 48, 51 and 60% with A. baumannii TonB-dependent
copper receptor, A. baumannii OMPA and A. baumannii 34 kDa
OMP, respectively (Table 1, Data S1, S2, and S3). For each
protein, Mascot probability based mowse score with protein score
greater than 84 are significant (p,0.05). To confirm the binding of
OMPA to fibronectin, we performed the same experiments with
the recombinant OMPA (rOMPA) produced by Escherichia coli.
Western blot analysis showed that rOMPA forms a stable complex
with fibronectin (Fig. 2B).
Involvement of fibronectin in the adherence of A.
baumannii to human lung epithelial cells
To evaluate the involvement of fibronectin in the A. baumannii
adherence to A549 cells, we studied the effect of fibronectin
inhibitor, RGD, and anti-human fibronectin antibody on A.
baumannii ATCC 19606, 77 or 113-16 strain adherence to A549
cells for 2 h. We showed that pretreatment of A549 cells with 0.5
and 1 mg/mL of RGD reduced significantly the adherence of
ATCC 19606, 77 and 113-16 strains to A549 cells to
72.0565.39% and 2666%, 61.74613.59% and 45.8861.43%,
and 41.4960.11% and 34.7467.68%, respectively (Fig. 3A).
Pretreatment of A549 cells with RGD did not affect the A549 cells
viability (data not shown). Similarly, pretreatment of A549 cells
with 28 mg/mL (1:25) anti-human fibronectin antibody reduced
significantly the adherence of ATCC 19606, 77 and 113-16 strains
to A549 cells to 65.9760.69%, 57.3360.29%, and 23.3362.93%,
respectively. In contrast, pretreatment of A549 cells with
unspecific antibody to fibronectin, a mouse IgG, or with rat
anti-human E-cadherin antibody, antibody against an irrelevant
epithelial surface protein cells, did not reduce significantly the
adherence of ATCC 19606, 77 and 113-16 strains to A549 cells
(Fig. 3B). The results obtained above with adherence assays were
confirmed by fluorescence microscopy experiments, with differ-
ential fluorescence labeling used to distinguish between A.
baumannii and fibronectin of A549 cells. After 2 h incubation of
A549 cells with A. baumannii ATCC 19606, 77 or 113-16 strain,
bacterial cells (green fluorescence) were colocalized with the
fibronectin (red fluorescence) in the cell membrane, indicating that
they were attached to A549 cells (Fig. 3C). Interestingly, the
interaction between A. baumannii and fibronectin was more evident
after 24 h of A549 cells incubation with A. baumannii strains. We
observed that bacterial cells (green fluorescence) were colocalized
with the fibronectin (red fluorescence) in the cell membrane and
inside the cell (Fig. 3D). Altogether, we found that fibronectin
plays an important role in the interaction between A. baumannii and
human lung epithelial cells.
Figure 1. Interaction of A. baumannii with immobilized fibro-
nectin. (A) A. baumannii binding to fibronectin. ATCC 19606, 77 or 113-
16 strains were incubated in BSA or in fibronectin-coated wells for 3 h
at room temperature. Adherent bacteria were quantified by serial
dilutions as described in materials and methods. (B) Inhibition of A.
baumannii adherence to immobilized fibronectin by free fibronectin.
ATCC 19606, 77 or 113-16 strain were incubated in fibronectin-coated
wells containing increasing concentrations of free fibronectin (0, 10, 100
and 1,000 mg/mL) or BSA (1,000 mg/mL). Adherent bacteria were
quantified by serial dilutions as described in materials and methods.
Results were expressed as the percentage of total untreated A.
baumannii adhered to immobilized fibronectin. Representative results
of three independent experiments are shown and data are the means6
SEM. P,0.05: * between untreated and treated groups. Fn: fibronectin
and BSA: bovine serum albumin.
doi:10.1371/journal.pone.0033073.g001
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Involvement of A. baumannii OMPA in the adherence of
A. baumannii to human lung epithelial cells
To demonstrate the involvement of OMPA, a FBP, in the A.
baumannii adherence to A549 cells, we studied the effect of mouse
anti-A. baumannii OMPA antibody on A. baumannii ATCC 19606,
77 or 113-16 strain adherence to A549 cells for 2 h. We showed
that pretreatment of A549 cells with OMPA antibody diluted at
1:1000 and 1:250 reduced significantly the adherence of ATCC
19606, 77 and 113-16 strains to A549 cells to 82.4668.77% and
63.64618.18%, 54.47621.56% and 29.17620.83%, and
67.0469.71% and 45.65613.04%, respectively (Fig. 4). In
contrast, pretreatment of A. baumannii strains with unspecific
antibody to fibronectin, a mouse IgG, or with rabbit anti-CarO of
A. baumannii antibody antibody against CarO which is an outer
membrane protein involved in the carbapenem permeability, did
not reduce significantly the adherence of ATCC 19606, 77 and
113-16 strains to A549 cells (Fig. 4). From these data, we found
that OMPA which is a FBP mediated the interaction between A.
baumannii and human lung epithelial cells.
Discussion
A. baumannii is an opportunistic pathogen that has emerged as a
problematic organism, causing severe infections in human hosts.
This is compounded by the fact that clinical isolates of this
organism are often resistant to multiple types of antimicrobial
therapies. To better understand the mechanisms involved in
pathogenicity with the long-term goal of finding targets for novel
therapies of the future, the work presented in this manuscript
focuses on the factor involved in the interaction of A. baumannii to
host cells.
A key virulence strategy of Gram-negative pathogens is their
ability to interact with proteins of the human serum or ECM.
These interactions are associated with bacterial immune evasion
or adherence to and invasion into host cells [15–17]. In this study,
we demonstrated that A. baumannii present specific ligands for
fibronectin confirming that fibronectin is a potential host for A.
baumannii. The fibronectin binding represents a preferential
receptor for different bacteria [18,19]. In addition, we showed
that A. baumannii binding to immobilized fibronectin is mediated
by the OMPs. The blocking of the immobilized fibronectin using
OMPs extracts, abolished attachment of A. baumannii to immobi-
lized fibronectin (data not shown). In agreement with this data,
previous studies demonstrate the role played by OMPs in the
bacterial binding to fibronectin [20–23]. Hence, A. baumannii
seems to possess the FBPs among their OMPs.
The identification of three FBPs, OMPA, TonB-dependent
copper receptor, and 34 kDa OMP, highlights the role of these
proteins in the interaction between A. baumannii and host cells. The
expression of these three FBPs was not affected by the acquired
resistance by A. baumannii. Although there is no experimental
evidence up to now, the interaction and the invasion of A.
baumannii contribute towards not only systemic infection but also
protect the bacteria from antibiotics leading their persistence in
the tissue [24,25].
Interestingly, we identified TonB-dependent copper receptor as
a FBP. TonB protein works as an energy transducer coupling
cytoplasmic membrane proton motive force to active transport of
iron-siderophores and vitamin B12 across the outer membrane of
E. coli and presumably of other gram-negative bacteria. The
Figure 2. Immunodetection of binding of fibronectin to outer
membrane proteins of A. baumannii and rOMPA. Immunodetec-
tion of FBPs outer membrane of A.baumannii ATCC 19606, 77 or 113-16
strain (A) and FBP rOMPA (B). OMPs were extracted from outer
membrane and rOMPA was produced in E. coli as described in materials
and methods and stained with SimplyBlueTM SafeStain (SDS-PAGE) or
electrotransferred onto nitrocellulose membrane, and incubated with
Fn. FBPs were probed with rabbit anti- human fibronectin and HRP-
conjugated goat anti-rabbit IgG (WB). Molecular mass standards (kDa)
are shown on the right. FBPs: fibronectin binding proteins, Fn:
fibronectin, MW: molecular weight, WB: western blot.
doi:10.1371/journal.pone.0033073.g002
Table 1. Identification of FBPs from A. baumannii ATCC 19606 by MALDI-TOF-TOF (MS-MS/MS) of selected bands.
Band (kDa) Sequence coverage (%) Peptide matched ID Protein
78.03 48 See Data S1 gi: 260557574 TonB -dependen t coppe r
receptor
36.94 51 See Data S2 gi: 129307154 Outer membrane protein A
32.09 60 See Data S3 gi: 184159810 34 kDa outer membrane
protein
doi:10.1371/journal.pone.0033073.t001
Acinetobacter baumannii Binding to Fibronectin
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function of TonB is apparently to transduce energy to the outer
membrane receptors, perhaps by releasing otherwise tightly bound
ligands into the periplasmic space [26,27]. Apart from its capacity
to transport molecules, in Pasteurella multocida and Bacteroides fragilis,
TonB is able to recognize and bind to fibronectin [22,28]. It also
has been suggested that TonB may allow some species to adhere to
and colonize different niches in the host [28]. Considering that A.
baumannii OMPA is involved in the interaction between A.
baumannii and human epithelial cells, in its translocation to
mitochondria and cell nucleus, and in its induction of the human
epithelial cell death [29–32], it is likely that OMPA binding to
fibronectin play an important role in this phenomena. In
agreement with our data, P. multocida have used OMPA to bind
to host cells and to interact with fibronectin [33]. In the case of the
34 kDa OMP, we suggest that this FBP is the same protein
previously described by different authors as being from 31 to
36 kDa or 33 to 36 kDa [34–36]. Similarly to OMPA, it was
reported that OMP 33–36 kDa induces the cell death of human
cervical epithelial cells (unpublished data). We suggest that this cell
death induced by OMP 33–36 kDa would be a consequence of the
interaction between OMP 33–36 kDa and host cells.
Adherence-inhibition assays conducted in the presence of
fibronectin inhibitor or anti-human fibronectin antibody suggests
that host fibronectin may be a specific receptor for A. baumannii. In
fiboronectin adherence-inhibition assays, the presence of endog-
enous fibronectin on the surface of human lung epithelial cells may
have facilitated the adherence of A. baumannii strains to human
lung epithelial cells. Presumably, pretreatment with fibronectin
inhibitor resulted in its binding to fibronectin on the surface of
A549 cells, thus preventing interaction between FBPs and the
endogenous cellular fibronectin on the surface of A549 cells.
Inhibition resulting from pretreatment of A549 cells with rabbit
anti-human fibronectin was more significant for 113-16 strain than
ATCC 19606 and 77 strains suggesting the complexity of
adherence for susceptible strains and the involvement of multiple
factors including other ECM molecules in the bacterium
adherence to host cells [33]. Similar results were reported for P.
multocida [28].
Figure 3. Involvement of fibronectin in the adherence of A. baumannii to human lung epithelial cells. A549 cells were pretreated with
RGD (0.5 and 5 mg/mL) (A), rabbit anti-human fibronectin (1:25), rat anti-human E-cadherin (1:25) or control mouse IgG (1:25) (B) and infected with
108 cfu/mL of A. baumannii ATCC 19606, 77 or 113-16 strain for 2 h. Adherence assay was performed as described in materials and methods. The
effect of treatment on A. baumannii adherence to A549 cells is expressed as the percentage of total untreated A. baumannii adhered to A549 cells.
Immunostaining for A549 cells fibronectin and A. baumannii OMPs in infected A549 cells with 108 cfu/mL A. baumannii ATCC 19606, 77 or 113 strains
for 2 h (C) and 24 h (D) were performed and imaged by immunofluorescence microscopy. Fibronectin of A549 cells and OMPs of A. baumannii strains
were detected by rabbit anti-human fibronectin and mouse anti-A. baumannii OMPs antibodies and labeled with Alexa594 and Alexa488-tagged the
secondary antibodies that appeared red and green, respectively. Blue staining shows the location of A549 cells nucleus. Representative results of
three independent experiments are shown and data are the means 6 SEM. P,0.05: * between untreated and treated groups. Fn: fibronectin and Ab:
antibody.
doi:10.1371/journal.pone.0033073.g003
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Several studies have shown bacterial adherence to host
fibronectin [20,37,38]. Bacteria, through their OMPs bind to
fibronectin [12]. Our data clearly show that OMPA bind to
fibronectin (Fig. 3). Pretreatment of A. baumannii with mouse anti-
A. baumannii OMPA prior incubation with A549 cells strongly
reduced the adherence of A. baumannii to A549 cells. Similar results
have been obtained with P. multocida OMPA [33].
In summary, all data reported here indicate that A. baumannii
binding to fibronectin was mediated by the OMPs. The OMPs
were identified as FBPs and were involved in the interaction
between A. baumannii and fibronectin. Our results encourage us to
continue our studies in an attempt to understand the involvement
of A. baumannii adherence to host cells in the pathogenesis of this
pathogen.
Materials and Methods
Bacterial strains
A. baumannii ATCC 19606 (LGC Standards, United Kingdom)
and clinical A. baumannii isolate 77, both susceptible to all
antimicrobials, and clinical pandrug-resistant A. baumannii isolate
113-16 were used. All strains were grown in a Mueller Hinton
Broth (MHB) at 37uC for 20–24 h.
Human cell culture and infection
Type II pneumocyte cell line A549 derived from a human
lung carcinoma (LGC Standards, United Kingdom) were grown
in DMEM medium supplemented with 10% heat-inactivated
foetal bovine serum (FBS), vancomycin (50 mg/mL), gentamicin
(20 mg/mL), amphoterecin B (0.25 mg/mL) (Invitrogen, Spain)
and 1% HEPES (Gibco, Spain) in a humidified incubator,
5% CO2 at 37uC. A549 cells were routinely passaged every
3–4 days. The cells were seeded 24 h in 24 well plates prior to
infection with A. baumannii strains at a multiplicity of infection
(MOI) of 100. Immediately before infection, A549 cells were
washed three times with prewarmed phosphate-buffered saline
(PBS) and further incubated in DMEM without FBS and
antibiotics.
Coating fibronectin on wells
Coating fibronectin on wells were performed in sterile 96 well
plates as described previously [23]. Briefly, wells were coated
overnight at 4uC with 1.25 mg of plasmatic fibronectin in PBS
(125 mL of fibronectin at 10 mg/mL per well) or with 20 mg/mL of
BSA. Then wells were washed four times with 125 mL of 1% (w/v)
BSA in PBS, and blocked for 1 h at room temperature with
125 mL of 1% BSA in PBS. Just before adding bacteria, wells were
washed six times with PBS.
Outer membrane preparations and rOMPA production
Outer membrane fraction from A. baumannii ATCC 19606, 77
or 113-16 strain were isolated as described previously [39]. Briefly,
1 L of MHB was inoculated with 5 mL of an overnight culture.
Bacterial cells were pelleted by centrifugation at 5,0006 g for
10 min, resuspended in 10 mL of 10 mM phosphate buffer,
pH 7.2, and lysed on ice by sonication for a total of 5–7 min in
30 s intervals. Unlysed cells were pelleted by centrifugation at
5,0006 g for 5 min, and the supernatant was centrifuged at
20,0006 g for 45 min at 4uC to pellet cell envelopes. Inner
membranes from the resulting pellet were solubilized for 30 min at
room temperature with 5 mL of 2% N-laurylsarcosinate in
10 mM phosphate buffer, pH 7.2. After solubilization, the
insoluble outer membrane fraction was pelleted by centrifugation
at 20,0006 g for 45 min at 4uC. The outer membrane fraction
was washed by resuspension in 2 mL 62.5 mM Tris-HCl, pH 6.8
and centrifuged at 20,0006 g for 45 min at 4uC. The resulting
pellet was stored at 280uC until use. rOMPA was produced from
E. coli as described previously by our group [40].
Fibronectin-binding assays
Fibronectin-binding assays were performed as described
previously [23], with some modifications. Briefly, A. baumannii
ATCC 19606, 77 or 113-16 strain grown overnight at 37uC in
MHB were resuspended in PBS and collected by centrifugation at
5,0006 g for 10 min. Bacteria were washed twice in sterile PBS
and resuspended in the same sterile buffer. Two assays were
performed: i) 50 mL of bacterial suspension were mixed with
50 mL of PBS, added to BSA or fibronectin coated wells and
incubated 3 h at room temperature, and ii) 50 mL of bacterial
suspension were mixed with increasing amounts of human
plasmatic fibronectin (0, 10, 100 and 1,000 mg/mL), added to
fibronectin coated wells and incubated 3 h at room temperature
for bacterial adsorption. After rinsing thrice with sterile PBS,
50 mL of bacterial suspension were added for 3 h at room
temperature for bacterial adsorption. Non-adhered bacteria were
discarded and wells were washed six times with sterile PBS to
remove unbound bacteria. Adherent bacteria were then collected
with 125 mL of sterile PBS containing 0.5% Triton X-100. Diluted
lysates were plated onto sheep blood agar (Becton Dickinson
Microbiology Systems, USA) and incubated at 37uC for 24 h for
enumeration of developed colonies and then the determination of
the number of bacteria that attached to fibronectin.
Figure 4. Involvement of A. baumannii OMPA in the adherence
of A. baumannii to human lung epithelial cells. A549 cells were
infected for 2 h with 108 cfu/mL of A. baumannii ATCC 19606, 77 or
113-16 strain previously incubated for 1 h with mouse anti-OMPA of A.
baumannii (1:1,000 and 1:250), rabbit anti-CarO of A. baumannii (1:25)
and control mouse IgG (1:25). Adherence assay was performed as
described in materials and methods. The effect of treatment on A.
baumannii adherence to A549 cells is expressed as the percentage of
total untreated A. baumannii adhered to A549 cells. Representative
results of three independent experiments are shown and data are the
means 6 SEM. P,0.05: * between untreated and treated groups.
OMPA: outer membrane protein A and Ab: antibody.
doi:10.1371/journal.pone.0033073.g004
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Sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) and immunoblotting assay
After the determination of the OMPs and rOMPA amounts by
using the bicinchoninic assay assay (Thermo Scientific, Spain),
three or six mg of proteins were mixed with an equal volume of 26
Laemmli buffer, denaturated by heating the mixture for 5 min at
95uC, and then resolved by 10% SDS-PAGE. The gels were
stained with SimplyBlueTM SafeStain following the manufacturer’s
instructions (Invitrogen, Spain).
Western blotting
To investigate the possible involvement of OMPs and OMPA in
the A. baumannii interactions with fibronectin, OMPs extracts and
rOMPA were used for western blotting. Western blotting analysis
was performed following the SDS-PAGE as indicated above. The
separated proteins were transferred using nitrocellulose mem-
branes (Amersham Bioscience, Spain), and the membranes were
blocked for 1 h with PBS and 0.1% (v/v) Tween 20 (PBST buffer)
containing 5% (w/v) milk. The nitrocellulose membranes were
then incubated with human fibronectin (10 mg/mL) for 1 h,
washed twice with PBST buffer, and incubated overnight at 4uC
with primary antibody: rabbit anti-human fibronectin (1:2,500
dilution) diluted in PBST buffer containing 5% milk. After
washing with PBST buffer, the membranes were incubated for 1 h
at room temperature with a horseradish peroxidase-conjugated
goat anti-rabbit IgG antibody (Amersham Bioscience, Spain)
(dilution 1:10,000) diluted in PBST buffer containing 5% milk.
Subsequently, immunoreactive proteins were visualized using the
enhanced chemiluminescence protocol (Super ECL, (Amersham
Bioscience, Spain).
For peptide mass fingerprinting, SimplyBlueTM SafeStain-
stained bands representing FnBPs were excised from SDS-PAGE
gel and sent to the Centro de Investigacio´n Prı´ncipe Felipe de
Valencia for MALDI-TOF-TOF (MS-MS/MS) analysis. Data
obtained from peptide mass fingerprinting were matched against
the NCBI database (http://www.ncbi.nlm.nih.gov) using the
Mascot program.
Immunofluorescence
A549 cells plated on coverslips in 24 well plates for 24 h and
infected with A. baumannii ATCC 19606, 77 or 113-16 strain at
37uC for 2 and 24 h were removed and washed five times with
cold PBS. A549 cells were fixed in methanol for 8 min at 220uC,
permeabilized with 0.5% Triton X-100 and blocked with 20%
porc serum in PBS. Primary antibodies: mouse anti-A. baumannii
OMPs [41] and rabbit anti-human fibronectin (Sigma, Spain)
were used at dilution of 1:50 and 1:400 in PBS containing 1% BSA
for 2 h, respectively. After washing with PBS, the coverslips were
incubated with the secondary antibodies: Alexa488-conjugated
goat anti-mouse IgG, and Alexa594-conjugated goat anti-rabbit
IgG (Invitrogen, Spain) at dilution of 1:100 and 1:800 in PBS
containing 1% BSA for 1 h, respectively. The fixed coverslips were
incubated for 10 min at room temperature with DAPI (Appli-
chem, Germany) (0.5 mg/mL), washed with PBS, mounted in
fluorescence mounting medium (Dako Cytomation, Spain), and
visualized using a Leica fluorescence microscope (DM-6000; Leica
Microsystems Wetzlar GmbH, Germany).
Adhesion assay
i) A549 cells were pretreated with RGD (0.5 and 1 mg/mL), a
fibronectin inhibitor, for 30 min, rabbit anti-human fibronectin
(28 mg/mL) for 60 min, mouse IgG (1:25) for 60 min, or with rat
anti-human E-cadherin (1:25) for 60 min and infected with
108 cfu/mL of A. baumannii ATCC 19606, 77 or 113-16 strain
for 2 h with 5% CO2 at 37uC. ii) A549 cells were infected for 2 h
in 5% CO2 at 37uC with 10
8 cfu/mL of A. baumannii ATCC
19606, 77 or 113-16 strain previously incubated for 1 h at room
temperature with mouse anti- A. baumannii OMPA (diluted in PBS
at 1:1,000 and 1:250), mouse IgG (1:25) for 60 min, or with rabbit
anti-A. baumannii CarO (1:25) kindly gift by AM Viale [42].
Subsequently, infected A549 cells were washed five times with
prewarmed PBS and lysed with 0.5% Triton X-100. Diluted
lysates were plated onto blood agar (Blood-Agar Columbia,
Becton Dickinson Microbiology Systems, USA) and incubated at
37uC for 24 h for enumeration of developed colonies and then the
determination of the number of bacteria that attached to A549
cells.
Statistical analysis
Group data are presented as mean 6 SEM. Student t-test was
used to determine differences between means. Difference was
considered significant at P,0.05. SPSS (version 15.0) statistical
package was used (SPSS Inc., Chicago, IL).
Supporting Information
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